Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subjective or objective: How the style of text in computational advertising influences consumer behaviors? | Fundam Res | 2022 | 39659878 | PubTator, text mining | PubMed |
| Ckmt1 is Dispensable for Mitochondrial Bioenergetics Within White/Beige Adipose Tissue. | Function (Oxf) | 2022 | 37954502 | PubTator, text mining | PubMed |
| Amyloid-like Hfq interaction with single-stranded DNA: involvement in recombination and replication in Escherichia coli. | QRB Discov | 2022 | 37529279 | PubTator, text mining | PubMed |
| Fast and powerful conditional randomization testing via distillation. | Biometrika | 2022 | 37416628 | PubTator, text mining | PubMed |
| Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards. | Addict Neurosci | 2022 | 37220637 | PubTator, text mining | PubMed |
| Plasmid-mediated quinolone resistance determinants in clinical bacterial pathogens isolated from the Western Region of Ghana: a cross-sectional study. | Pan Afr Med J | 2022 | 36942137 | PubTator, text mining | PubMed |
| p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma. | Front Oncol | 2022 | 36776364 | PubTator, text mining | PubMed |
| Chemo-immunoablation of solid tumors: A new concept in tumor ablation. | Front Immunol | 2022 | 36713427 | PubTator, text mining | PubMed |
| Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin. | Front Psychiatry | 2022 | 36699502 | PubTator, text mining | PubMed |
| ESR1 fusions and therapeutic resistance in metastatic breast cancer. | Front Oncol | 2022 | 36686845 | PubTator, text mining | PubMed |
| The role played by ailanthone in inhibiting bone metastasis of breast cancer by regulating tumor-bone microenvironment through the RANKL-dependent pathway. | Front Pharmacol | 2022 | 36686653 | PubTator, text mining | PubMed |
| Functional Validation of the Putative Oncogenic Activity of PLAU. | Biomedicines | 2022 | 36672610 | PubTator, text mining | PubMed |
| Homozygous GRHPR C.494G>A mutation is deleterious that causes early onset of nephrolithiasis in West Bengal, India. | Front Mol Biosci | 2022 | 36619171 | PubTator, text mining | PubMed |
| Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors. | Front Immunol | 2022 | 36618378 | PubTator, text mining | PubMed |
| "NIR-triggered ROS storage" photodynamic intraocular implant for high-efficient and safe posterior capsular opacification prevention. | Asian J Pharm Sci | 2022 | 36600895 | PubTator, text mining | PubMed |
| Role of mechano-sensitive non-coding RNAs in bone remodeling of orthodontic tooth movement: recent advances. | Prog Orthod | 2022 | 36581789 | PubTator, text mining | PubMed |
| High p62 expression suppresses the NLRP1 inflammasome and increases stress resistance in cutaneous SCC cells. | Cell Death Dis | 2022 | 36581625 | PubTator, text mining | PubMed |
| Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation. | Front Pharmacol | 2022 | 36569288 | PubTator, text mining | PubMed |
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial. | BMJ Open | 2022 | 36564123 | PubTator, text mining | PubMed |
| Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems. | Pathogens | 2022 | 36558778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=31